MedPath

High Flow Nasal Cannula Treatment for Viral Bronchiolitis in Infants, a Randomised Controlled Trial

Not Applicable
Active, not recruiting
Conditions
Viral bronchiolitis
Respiratory - Other respiratory disorders / diseases
Infection - Other infectious diseases
Registration Number
ACTRN12613000388718
Lead Sponsor
Andreas Schibler
Brief Summary

Our randomized controlled trial in infants with bronchiolitis treated outside of an intensive care setting demonstrated a significantly lower escalation of care and treatment failure rate when high-flow was used early during the hospital admission as compared to standard-oxygen therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
1472
Inclusion Criteria

Inclusion criteria are infants with a clinical diagnosis of bronchiolitis less than 12 months corrected age (greater than or equal to 37 weeks post-conceptional age) with an oxygen requirement in room air of SpO2 < 92% for tertiary centres and <94% for regional and metropolitan centres.

Exclusion Criteria

craniofacial malformation
impending intubation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath